Free Trial

Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Consensus Rating of "Moderate Buy" from Brokerages

Crescent Capital BDC logo with Finance background

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) have earned an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $19.00.

CCAP has been the subject of several research analyst reports. Bank of America cut their target price on shares of Crescent Capital BDC from $20.00 to $19.00 and set a "buy" rating for the company in a research note on Thursday, August 15th. LADENBURG THALM/SH SH assumed coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They set a "buy" rating and a $20.00 price objective on the stock. Finally, Wells Fargo & Company dropped their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 14th.

Check Out Our Latest Stock Report on CCAP

Crescent Capital BDC Stock Up 0.6 %

CCAP traded up $0.11 on Tuesday, reaching $19.12. 55,954 shares of the company traded hands, compared to its average volume of 132,058. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. The company has a market cap of $708.63 million, a price-to-earnings ratio of 7.47 and a beta of 0.81. Crescent Capital BDC has a 52-week low of $15.91 and a 52-week high of $19.63. The stock's 50 day moving average price is $18.46 and its 200-day moving average price is $18.45.

Crescent Capital BDC Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.42 per share. The ex-dividend date is Tuesday, December 31st. This represents a $1.68 annualized dividend and a yield of 8.79%. This is an increase from Crescent Capital BDC's previous quarterly dividend of $0.07. Crescent Capital BDC's dividend payout ratio is 65.88%.

Institutional Trading of Crescent Capital BDC

Large investors have recently modified their holdings of the business. HighTower Advisors LLC increased its stake in shares of Crescent Capital BDC by 0.5% during the third quarter. HighTower Advisors LLC now owns 141,838 shares of the company's stock valued at $2,624,000 after buying an additional 768 shares during the period. Confluence Investment Management LLC increased its stake in shares of Crescent Capital BDC by 2.2% during the third quarter. Confluence Investment Management LLC now owns 73,206 shares of the company's stock valued at $1,354,000 after buying an additional 1,583 shares during the period. Point72 Asset Management L.P. purchased a new stake in Crescent Capital BDC in the second quarter worth $90,000. Sumitomo Mitsui Trust Holdings Inc. grew its stake in Crescent Capital BDC by 14.1% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 80,766 shares of the company's stock worth $1,517,000 after purchasing an additional 10,000 shares during the period. Finally, XTX Topco Ltd purchased a new stake in Crescent Capital BDC in the second quarter worth $195,000. Institutional investors own 49.46% of the company's stock.

About Crescent Capital BDC

(Get Free Report

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Read More

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Should you invest $1,000 in Crescent Capital BDC right now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines